Medical Diagnostics

KineMed Inc.

Brief Descriptiom

This field-leading biotech company worked with major pharmaceutical and biotechnology companies to produce data on target engagement, toxicity and disease progression to accelerate drug development and reduce the overall costs and risks. The pathway-based drug discovery and development company was founded to identify active drug candidates preclinically and confirm their therapeutic activity. The company helped in expediting the drug development process and provided real-time insight into conditions including metabolic disorders, cancer, and diseases of inflammation and...

KaRNAteq, Inc.

Brief Description

KaRNATeq develops tools for RNA sequencing that are the next step forward in genomics. The enzymes developed by the company enable doctors and scientists to capture more information at reduced cost.

Inventors

Kathleen Collins, Heather Upton

Company Founders

Kathleen Collins, Robert Klein (UC Berkeley, BA, Biochemistry, ’86; Ph.D.)

Timeline 2019. Company founded

Correlia Biosystems, Inc.

Brief Description

Correlia Biosystems develops streamlined assay platforms to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications. Our research instruments provide multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation. The company is dedicated to reducing the cost and time to market for candidate drug compounds, and facilitating the access of researchers to large panel protein studies. The company's biomeasurement technology serves the world's top 20...

CellScope Inc.

Brief Description

CellScope’s mission is to make healthcare more accessible and convenient. We are building smart mobile tools to empower families with easy access to health answers and care when they need it most.

CellScope was acquired. The details are not yet public.

Inventors

David Breslauer, Jesse Dill, Erik Douglas, Daniel Fletcher, Wendy Hansen, Wilbur Lam, Robi Maamari, Amy Sheng, Neil Switz

Company Founders

Erik Douglas (UC Berkeley, Ph.D., Bioengineering), Amy Sheng (UC Berkeley, MBA ’13)

Timeline 2010. Company founded

C. Light Technologies, Inc.

Brief Description

C. Light Technologies, Inc. is revolutionizing the way we detect, monitor, and treat multiple sclerosis (MS) through the use of a patented, non-invasive, IRB-approved retinal eye-tracker - the tracking scanning laser ophthalmoscope (TSLO) with accompanying machine learning algorithms. In the future, our vision is to use the TSLO for other applications, including concussions, Parkinson’s, ALS, and Alzheimer’s.

Inventors

Austin John Roorda, Pavan Kumar Tiruveedhula, Christy Sheehy-Bensinger, William Tuten, and Qiang Yang

Company Founders

Christy Sheehy (UC...

BioScale, Inc.

Brief Description

BioScale developed diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes, and cardiovascular disease. The company's algorithms utilized combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. BioScale's rigorous approach to test development included collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts.

Bioscale...

BioAmp Diagnostics

Brief Description

BioAmp develops novel, instrument-free screening and diagnostic tools to identify antibiotic-resistant bacteria in patient samples.

Inventors

Tara DeBoer, Niren Murthy, Jessica Marie Palomino, Lee Woodland Riley

Company Founders

Tara DeBoer

Timeline 2017. Company founded, and participated in the Citris Foundry accelerator program

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...